BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for BBOT. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 62 institutions reported holding BBOT, with 58.9 million shares worth $449.2 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Cormorant Asset Management | 17,878,594 | $136M | UNCHANGED |
| Deerfield Management Company | 4,885,446 | $37M | UNCHANGED |
| Omega Fund Management | 3,289,661 | $25M | UNCHANGED |
| Ecor1 Capital | 2,823,126 | $22M | UNCHANGED |
| Alphabet | 2,823,126 | $22M | UNCHANGED |
Full institutional holdings, insider history, and congressional trades for BridgeBio Oncology Therapeutics, Inc. Common Stock on SentiSense.